NewEdge Advisors’s Alpine Immune Sciences Inc ALPN Stock Holding History

NewEdge Advisors’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-469	Closed	-$18.6K	–	4050
2024 Q1	$18.6K	Hold	469	–	–	﹤0.01%	2654
2023 Q4	$8.94K	Buy	469 +344	+275%	+$4.78K	﹤0.01%	2905
2023 Q3	$1.43K	Buy	+125	New	+$1.54K	﹤0.01%	3111

NewEdge Advisors's ALPN Position: Q2 2024 in Review

NewEdge Advisors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 469 shares — an estimated $18.6K sold.

NewEdge Advisors first reported a position in ALPN in Q3 2023 and held it in 3 quarters. The position peaked at $18.6K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

NewEdge Advisors reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
NewEdge Advisors sold 469 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $18.6K.
NewEdge Advisors first reported a position in Alpine Immune Sciences Inc in Q3 2023 and held it in 3 quarters.
NewEdge Advisors's Alpine Immune Sciences Inc position peaked at $18.6K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on NewEdge Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.